About Pyrazinamide Dosing

This guide provides supplementary information for the Pyrazinamide Dose Calculator (TB). Pyrazinamide is a critical first-line medication used in combination with other drugs to treat active tuberculosis (TB). Proper dosing is essential for treatment efficacy and to minimize the risk of adverse effects, particularly liver toxicity. Dosing is primarily based on patient weight and adjusted for dosing frequency and renal function.

Calculator Outputs Explained

The tool calculates and displays the following key information for a single dose administration:

  • Dose Range (mg): The acceptable minimum and maximum dose in milligrams based on the patient’s weight and dosing frequency.
  • Recommended Dose (mg): A specific, calculated dose intended for practical administration. This value is typically rounded to the nearest half-tablet (250 mg) for ease of use, assuming 500 mg tablets.
  • Tablets to Administer: The number of 500 mg tablets required to achieve the recommended dose.

How to Use the Calculator

To ensure an accurate calculation, follow these steps:

  1. Enter Patient Weight: Input the patient’s current body weight.
  2. Select Weight Unit: Choose either kilograms (kg) or pounds (lbs). The calculator will convert lbs to kg for the calculation.
  3. Enter Creatinine Clearance (CrCl): If the patient has known renal impairment, enter their CrCl in mL/min. If renal function is normal (CrCl ≥30 mL/min) or unknown, this field can be left blank. The tool assumes normal function if no value is provided.
  4. Select Dosing Frequency: Choose the prescribed administration schedule: Daily, 3 times per week, or 2 times per week. The calculator will automatically adjust the frequency for patients with severe renal impairment (CrCl < 30 mL/min).

Dosing Overview

The calculator’s logic is based on established clinical guidelines for tuberculosis treatment. The dose per kilogram varies significantly with the dosing schedule.

Dosing FrequencyDose Range (mg/kg)Maximum Dose (mg)
Daily (7 days/week)20–30 mg/kg2,000 mg
3 times per week40–60 mg/kg4,000 mg
2 times per week40–60 mg/kg4,000 mg

Renal Impairment Adjustment

For patients with severe renal impairment (CrCl <30 mL/min), pyrazinamide clearance is reduced. Guidelines recommend adjusting the dosing schedule to 3 times per week, regardless of the initial frequency selected. The calculator performs this adjustment automatically when a CrCl value below 30 is entered.

Switching Treatment Regimens

Any modification to a tuberculosis treatment plan, including changes in dosing frequency or medication, is a significant clinical decision. Switching between daily and intermittent therapy should only be done under the supervision of a healthcare professional experienced in TB management, as it can impact treatment outcomes and drug resistance.

Missed Dose Protocol

If a dose of pyrazinamide is missed, the patient should contact their healthcare provider or pharmacist for guidance. They should not take a double dose to make up for the missed one. The advice will depend on how much time has passed since the dose was due and the overall treatment plan.

Safety Alerts

Pyrazinamide carries important safety considerations that require clinical monitoring:

  • Hepatotoxicity: The most significant adverse effect is liver injury. Patients should be monitored for signs of hepatitis (e.g., fatigue, jaundice, abdominal pain) and have baseline and follow-up liver function tests.
  • Hyperuricemia: The drug consistently increases uric acid levels and can precipitate gouty arthritis.
  • Contraindications: Pyrazinamide is contraindicated in patients with severe liver damage or acute gout.
Disclaimer: This information is for educational purposes and does not replace professional medical advice. All dosing calculations must be confirmed by a qualified clinician before administration.

Frequently Asked Questions (FAQ)

Why did the calculator change my selected dosing frequency?

If you entered a Creatinine Clearance (CrCl) value less than 30 mL/min, the calculator automatically adjusted the dosing frequency to “3 times per week” as recommended by clinical guidelines for patients with severe renal impairment.

What if the patient’s CrCl is unknown?

If the CrCl field is left blank, the calculator assumes normal renal function (CrCl ≥30 mL/min) and uses the dosing frequency you selected.

Is the recommended dose an exact calculation?

The recommended dose is derived from the patient’s weight but is then rounded to the nearest 250 mg (half of a 500 mg tablet) to provide a practical dose that can be easily administered in a clinical setting.

What is the maximum dose of pyrazinamide?

The maximum dose depends on the frequency. For daily dosing, it is 2,000 mg. For intermittent dosing (2 or 3 times per week), the maximum dose is 4,000 mg. The calculator will cap the recommended dose at these limits.

Why is the intermittent dose (mg/kg) higher than the daily dose?

Intermittent dosing involves giving larger, less frequent doses to maintain therapeutic drug levels over time. This approach has been shown to be effective and is often used to facilitate directly observed therapy (DOT).

What tablet strength does the calculator use?

The calculation for the number of tablets to administer assumes a standard formulation of 500 mg pyrazinamide tablets.

Can this calculator be used for pediatric patients?

This calculator is designed for adult dosing. Pediatric dosing for TB is complex and often involves different weight-based formulas and liquid formulations. Consult pediatric-specific guidelines for dosing in children.

Who is this tool intended for?

This tool is intended for use by qualified healthcare professionals (doctors, pharmacists, nurses) as a support tool for calculating pyrazinamide doses. It is not for patient self-dosing.

References

  1. Centers for Disease Control and Prevention (CDC). Treatment of Drug-Susceptible Tuberculosis. Official American Thoracic Society/CDC/Infectious Diseases Society of America Clinical Practice Guidelines, 2016.
  2. World Health Organization (WHO). Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update).
  3. U.S. Food and Drug Administration (FDA). Pyrazinamide Tablets, USP Prescribing Information.
PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators